Skip to main content

Immuno Oncology Assays Market | Rising Incidence of Cancer Driving Market Growth

The market for immuno oncology assays is expected to reach USD 5.9 billion by 2024 from USD 2.9 billion in 2018, at a CAGR of 12.7% during the forecast period. The growth of this market is primarily driven by factors such as the increasing adoption of targeted therapy over traditional therapy and increasing demand for mAbs. However, the high cost of immunotherapy treatment and the high attrition rate in the product development cycle are the major factors that are expected to restrain the growth of this market during the forecast period.


Based on products, the immuno-oncology assays market is segmented into consumables and software. The consumables segment dominated the market with the largest share in 2018; this segment is also expected to register the highest CAGR during the forecast period. The large share of this segment can be attributed to the availability of a wide range of reagents and kits, increasing use of reagents in different oncology therapeutic treatments, increasing research on cancer immunotherapy biomarkers and its applications in drug development, and easy accessibility to a wide range of reagents.

Download FREE Brochure:

Based on application, the immuno-oncology assays market is segmented into research applications and clinical diagnostics. Research applications dominated the market with the largest share in 2018. It is also projected to be the fastest-growing segment during the forecast period. The rising prominence of biomarker-based drug development and clinical trials and the emergence of cancer immunotherapy are the key factors driving market growth.
The immuno oncology assays market is divided into four major regions— North America, Europe, Asia Pacific, and the Rest of the World (RoW).

Asia Pacific is estimated to grow at the highest CAGR during the forecast period. The growing number of CROs in the region, increasing awareness about early detection of cancer, and the shift of manufacturers’ and suppliers’ focus from developed economies to emerging economies are some factors supporting the growth of this region.

Comments

Popular posts from this blog

A Best e-Commerce Platform for B2B & B2C Businesses – STORM

  Storm eCommerce platform is one of the modern, scalable, and advanced, eCommerce platforms, designed for online merchants who deal with several transactions. Smaller online retailers with rapidly growing business may also choose this product. Developed in 2008, Storm Commerce has turned out to be a useful platform with eCommerce solutions. Storm Commerce is mainly equipped with B2B functionalities, automated technologies, and user-friendly interface. USP of This Platform: Storm eCommerce platform is a seamless platform and its customized solutions can manage several deals of B2B and B2C businesses. The automation technologies have helped businesses to ensure an increased profitability, higher performance, and smarter workflows. As one of the cloud SaaS solutions, Storm is valuable for its performance and high capacity. The open APIs of Storm enable users to integrate a CMS and different other systems. It helps in developing omni-channel commerce with its features and functionalit...

Cell Sorting Market

The global  cell sorting market  is projected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% in the forecast period (2016-2021). Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of global Market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of market. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and RoW. Among the four geographic regions, North America is estimated to command the largest share of the market in 2016, foll...

Diagnostic Catheter Market: What Will be the Growth Scenario in the next five years?

 The overall diagnostic catheters market is projected to reach USD 4,302.3 million by 2021 from USD 3,025.8 million in 2016, at a CAGR of 7.3% from 2016 to 2021. Advancements in medical imaging technologies, increasing number of minimally invasive procedures, launch of new technologies in terms of catheter design, and rising geriatric population (resulting in a subsequent growth in the prevalence of chronic disorders) are primarily expected to drive growth in the global market. However, factors such as dearth of skilled professionals, high cost of technologically advanced catheters, and the trend of reusing single-use diagnostic catheters are expected to restrain market growth to a certain extent. Growing preference of OCT imaging catheters in intravascular diagnostics and imaging: OCT has revolutionized the medical imaging industry and has extended its applications in disease diagnosis and imaging of various cellular and molecular processes in vivo. The success...